Clinical trial
Effects of Short-term and Perioperative Antiviral Therapy on Prognosis After Hepatectomy for Hepatitis B Virus-related Hepatocellular Carcinoma
NCT05406089 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Short-term and Perioperative Antiviral Therapy on Prognosis After Hepatectomy for Hepatitis B Virus-related Hepatocellular Carcinoma
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2016
- Completion date
- June 30, 2019
- Enrollment
- 494 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b virus, hepatocellular carcinoma, survival